RGEN - REPLIGEN CORP


125.84
2.780   2.209%

Share volume: 666,470
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%

$123.06
2.78
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-01-2024 07-30-2024 11-18-2024 03-13-2025 04-29-2025 08-07-2025 11-04-2025 02-26-2026
Cash flow financing -8.974 M -5.773 M -69.604 M 1.449 M -5.030 M -10.131 M -239.000 K 195.000 K
Other financing cash flows 0.000 0.000 32.000 K 1.449 M -5.030 M -10.131 M -239.000 K 195.000 K
Cash flow 44.708 M 42.190 M -26.143 M -24.137 M -64.133 M 10.639 M 40.077 M -182.845 M
Net income 2.094 M 3.321 M -654.000 K -33.869 M 5.830 M 14.866 M 14.911 M 13.287 M
Depreciation 16.791 M 16.857 M 17.658 M 18.367 M 18.704 M 20.081 M 20.009 M 19.951 M
Changes in inventories 198.033 M 190.528 M 0.000 0.000 3.828 M 0.000 0.000 0.000
Changes in receivables 115.766 M 123.245 M 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -8.362 M -7.400 M -5.859 M -64.762 M -74.108 M -7.839 M -7.783 M -208.744 M
Net Borrowings -234.805 M -256.923 M 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures -8.373 M -7.400 M 6.983 M 5.540 M 3.521 M 7.101 M 4.702 M 7.957 M
Cash Change 780.617 M 809.146 M -25.182 M -26.609 M -60.126 M 11.626 M 39.892 M -182.726 M